Natus Medical Cash and Equivalents USD Trend

BABY -- USA Stock  

USD 36.05  0.10  0.28%

This module enables investors to look at Natus Medical various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 42.4 M, Cost of Revenue of 152.7 M or Earning Before Interest and Taxes EBIT of 56.5 M, but also many exotic indicators such as Interest Coverage of 194, Long Term Debt to Equity of 0.1056 or Calculated Tax Rate of 32.5157. This module is a perfect complement to use when analyzing Natus Medical Valuation or Volatility. It can also complement various Natus Medical Technical models. Check also analysis of Natus Medical Correlation with competitors.
Showing smoothed Cash and Equivalents USD of Natus Medical Incorporated with missing and latest data points interpolated. Cash and Equivalents in USD, converted by [FXUSD].
Cash and Equivalents USD10 Years Trend
Increasing
Slightly volatile
 Cash and Equivalents USD 
      Timeline 

Regression Statistics

Arithmetic Mean  77,235,308
Geometric Mean  53,784,845
Coefficient Of Variation  91.62
Mean Deviation  54,835,349
Median  56,106,000
Standard Deviation  70,763,885
Range  201,635,000
R Value  0.80
R Squared  0.64
Significance  0.001097
Slope  14,487,374

Natus Medical Cash and Equivalents USD Over Time

2016-12-31  213,551,000 
2017-12-31  213,551,000 
2018-12-31  155,800,000 

Other Fundumenentals

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Upcoming Events

Natus Medical Upcoming Company Events
Upcoming Quarterly ReportApril 19, 2017
Next Earnings ReportJuly 19, 2017
Check also analysis of Natus Medical Correlation with competitors. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.